FDA 483 OBSERVATION · #264 OF 1,000 MOST-CITED
Records review prior to shipment for slaughter
FDA cited this observation 111 times across 111 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1.1× the rate of the average FDA-cited firm (8.1% vs 7.7%), across 111 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
You did not review treatment records, prior to shipment of an animal for slaughter for human food, to assure that drugs have been used only as directed and that appropriate withdrawal periods have been met.
You did not review treatment records, prior to shipment of an animal for slaughter for human food, to assure that drugs have been used only as directed and that appropriate withdrawal periods have been met.
You did not review treatment records, prior to shipment of an animal for slaughter for human food, to assure that drugs have been used only as directed and that appropriate withdrawal periods have been met.
You did not review treatment records, prior to shipment of an animal for slaughter for human food, to assure that drugs have been used only as directed and that appropriate withdrawal periods have been met.
You did not review treatment records, prior to shipment of an animal for slaughter for human food, to assure that drugs have been used only as directed and that appropriate withdrawal periods have been met.
You did not review treatment records, prior to shipment of an animal for slaughter for human food, to assure that drugs have been used only as directed and that appropriate withdrawal periods have been met.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.
Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.